Connection
Christina Chambers to Isoxazoles
This is a "connection" page, showing publications Christina Chambers has written about Isoxazoles.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.657 |
|
|
|
-
Chambers CD, Johnson DL, Robinson LK, Braddock SR, Xu R, Lopez-Jimenez J, Mirrasoul N, Salas E, Luo YJ, Jin S, Jones KL. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum. 2010 May; 62(5):1494-503.
Score: 0.308
-
Lyons Jones K, Johnson DL, Chambers CD. Monitoring leflunomide (Arava) as a new potential teratogen. Teratology. 2002 May; 65(5):200-2.
Score: 0.177
-
Cassina M, Johnson DL, Robinson LK, Braddock SR, Xu R, Jimenez JL, Mirrasoul N, Salas E, Luo YJ, Jones KL, Chambers CD. Pregnancy outcome in women exposed to leflunomide before or during pregnancy. Arthritis Rheum. 2012 Jul; 64(7):2085-94.
Score: 0.090
-
Chambers CD. Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens. Congenit Anom (Kyoto). 2011 Mar; 51(1):16-20.
Score: 0.082